Call for Abstracts
Abstract submission is now open for AOCNMB 2026

The Scientific Committees of the 18th Asia Oceania Congress of Nuclear Medicine & Biology (AOCNMB 2026) and the 3rd SSNMMI International Conference are pleased to invite researchers, physicians, scientists, technologists, medical physicists, radiopharmacists, and healthcare professionals to submit their scientific abstracts.

This congress provides an international platform to present the latest research, clinical innovations, and technological advances in Nuclear Medicine, Molecular Imaging, Theranostics, and Precision Medicine.

We welcome submissions of both Original Research and Case Reports, with accepted abstracts presented as either Oral or Poster Presentations, as determined by the Scientific Committee.

Abstract Categories:

  • General Nuclear Medicine & SPECT/CT

  • PET/CT & Hybrid Imaging

  • Oncology & Molecular Imaging

  • Theranostics & Precision Medicine

  • NM Technology & Radiopharmaceutical Sciences

  • Physics, Instrumentation & Quantitative Imaging

  • Artificial Intelligence & Computational Imaging

  • Case Reports

Important Dates:

Abstract Submission Deadline: 13, September, 2026

Notification of Acceptance: 02, November, 2026

Final Presentation Upload: 24, November, 2026

For complete submission instructions, formatting requirements, important dates, and detailed terms & conditions,
please download the documents below before submitting your abstract.

AOCNMB2026 - CALL FOR ABSTRACTS, TERMS & CONDITIONS - Abstract_Template
Download

To submit your abstract, please complete the required documents and send them to: Abstract@AOCNMB2026.com

Submit Your Abstract
Download Template
Academic Submissions Open

Submit Your Radionuclide Research

Present your peer-reviewed molecular imaging data and targeted radionuclide therapy research at the premier global symposium bridging clinical oncology and radiopharmacy.

Submission Method

The Peer-Review Process

01
02
03

Verify Formatting

Select Category

Upload Manuscript

Ensure your manuscript adheres to the official template and includes complete dosimetry metrics.

Categorize your abstract under targeted radionuclide therapies or clinical molecular diagnostics.

Submit your finalized PDF document via the secure portal before the absolute deadline.

Evaluation Criteria
Critical Date

Rigorous Peer Review

Oct 15

Submission Deadline

All submitted abstracts undergo a strict double-blind peer-review process managed by our international scientific committee. Accepted papers will be published in the official congress proceedings and indexed accordingly.

Late submissions will automatically be deferred to the following cycle.

Authors of highly-rated abstracts will be invited to deliver oral presentations during the plenary sessions.

Academic Portal

Begin Submission

Provide your academic credentials and upload your abstract file. Ensure all co-authors are listed.